← Back to Search

Ketone Monoester

BHB supplement for High Blood Pressure (BHB Trial)

N/A
Waitlist Available
Led By Eléonor Riesco, PhD
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, before supplements' ingestion, each 20 minutes post-dose and during the subsequent 24 hours

Summary

This trial will assess whether acute consumption of a ketone monoester supplement can lower blood pressure and improve glucose control in healthy adults.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, before supplements' ingestion, each 20 minutes post-dose and during the subsequent 24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, before supplements' ingestion, each 20 minutes post-dose and during the subsequent 24 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in blood pressure and ambulatory blood pressure
Effect on glucose homeostasis
Secondary study objectives
Changes in IL-10 inflammatory profile
Changes in transcriptomic analyses of peripheral blood mononuclear cells

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: BHB supplement conditionExperimental Treatment1 Intervention
Group II: Placebo solution conditionPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

University of British ColumbiaOTHER
1,466 Previous Clinical Trials
2,485,441 Total Patients Enrolled
Université de SherbrookeLead Sponsor
304 Previous Clinical Trials
76,714 Total Patients Enrolled
Eléonor Riesco, PhDPrincipal InvestigatorUniversité de Sherbrooke

Media Library

BHB supplement (Ketone Monoester) Clinical Trial Eligibility Overview. Trial Name: NCT05794802 — N/A
High Blood Pressure Research Study Groups: Placebo solution condition, BHB supplement condition
High Blood Pressure Clinical Trial 2023: BHB supplement Highlights & Side Effects. Trial Name: NCT05794802 — N/A
BHB supplement (Ketone Monoester) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05794802 — N/A
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top